echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Zuoli Pharmaceutical Co., Ltd.: Coji Pharmaceutical Co., Ltd., a joint stock company, submits a listing application to the Hong Kong Stock Exchange

    Zuoli Pharmaceutical Co., Ltd.: Coji Pharmaceutical Co., Ltd., a joint stock company, submits a listing application to the Hong Kong Stock Exchange

    • Last Update: 2021-03-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 28, Zuoli Pharmaceutical issued an announcement stating that the company’s grandson company, Zhejiang Zuoli Innovation Medical Investment Management Co.


    Keji Pharmaceutical is a clinical stage biopharmaceutical company operating in China and the United States, focusing on innovative cell therapies for the treatment of solid tumors and hematological malignancies.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.